A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 11, 2022

Primary Completion Date

July 17, 2024

Study Completion Date

May 9, 2025

Conditions

Solid Tumors

Interventions

DRUG

BI 907828

DRUG

Rifampicin

DRUG

Itraconazole

Trial Locations (7)

Brussels - UNIV Saint-Luc, Brussels

Wilrijk - HOSP GZA (St-Augustinus), Wilrijk

Fundación Jiménez Díaz, Madrid

CIO Clara Campal, Madrid

Hospital Quirónsalud Madrid, Madrid

Hospital Quiron. I.C.U., Barcelona

Hospital Vall d'Hebron, Barcelona